BackVir Biotechnology Overview

Vir Biotechnology Receivables

Track Vir Biotechnology's receivables ($8.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$8.70M

Peer trimmed avg / median

Loading

Vir Biotechnology Receivables History

Loading

Vir Biotechnology vs. peers: Receivables Comparison

Loading

Vir Biotechnology Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Vir Biotechnology (VIR) FAQ

Vir Biotechnology (VIR) currently reports a receivables of $8.7M as of September 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Vir Biotechnology's receivables history and peer comparisons.

Vir Biotechnology's receivables changed from $0 to $8.7M (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vir Biotechnology reported $8.7M in receivables as of September 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $8.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vir Biotechnology, and consider following VIR for alerts when major investors trade the stock.

Vir Biotechnology is classified in the Healthcare sector. On receivables, it currently shows $8.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VIR with unrelated industries.